Drug delivery to the posterior eye segment can be challenging and is mostly achieved via intravitreal injections.3 Chorioretinal diseases often affect both eyes; hence, bilateral intravitreal injections of anti-VEGF are required. Here, VEGFA is linked to chorioretinitis.